CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | LOUMEAU ERIC J COO, General Counsel | Exercise or conversion | +10,000 | $14.02 | $140K | 10,000 |
| 2021-02-12 | LOUMEAU ERIC J COO, General Counsel | Sale | −10,000 | $35.00 | $350K | 0 |
| 2021-02-12 | LOUMEAU ERIC J COO, General Counsel | Exercise or conversion · Stock Option (right to buy) | −10,000 | 88,000 | ||
| 2021-02-10 | RENTON HOLLINGS Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-02-10 | Lizzul Paul F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2021-02-10 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-02-10 | Hamill Laura Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-02-10 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-02-10 | Topper James N Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-02-10 | Suria Hamza President, CEO | Grant or award · Stock Option (right to buy) | +119,700 | 119,700 | ||
| 2021-02-10 | LOUMEAU ERIC J COO, General Counsel | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2021-02-10 | MULROY DENNIS Chief Financial Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2021-02-10 | FENTON DENNIS M Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-02-10 | Ware J. Anthony Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-01-18 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-01-18 | Marquet Magda Director | Grant or award · Stock Option (right to buy) | +784 | 784 | ||
| 2020-11-16 | Topper James N Director | Other disposition | −973,612 | 0 | ||
| 2020-11-16 | Topper James N Director | Other disposition | −344,860 | 700,171 | ||
| 2020-11-16 | Topper James N Director | Other disposition | −98,275 | 199,529 | ||
| 2020-11-16 | Topper James N Director | Other acquisition | +22,604 | 54,458 |
Page 25 of 27 · 522 trades